| [1] |
HUANG Dongqiang, ZHOU Jinyu, LIU Yixian, LI Zhenyu.
Analysis of Technical Review of Drug Re-Registration in Hainan Province
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(3): 161-165.
|
| [2] |
RONG Hongguo, GUO Xinyue, LI Zihan, YANG Xiangxiang, SUN Xin, GUO Huijuan.
Historical Evolution and Modern Clinical Application of Jingui Shenqi Pill
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(1): 16-20.
|
| [3] |
YAN Ruoxi.
The Discussion of Management Review and Analysis of Common Deficiencies in Good Manufacturing Practice for Medicine
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(1): 78-80.
|
| [4] |
ZHAO Yi, HAN Zhao-zhao.
Review Requirements and Key Considerations for Reference Interval of In Vitro Diagnostic Reagents
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2024, 41(6): 432-435.
|
| [5] |
PENG Pu1, ZHU Chuan-qing1, ZHU Peng-zhi1, ZHANG Shi-qing2, ZHANG Qi2.
Research on the FDA Innovation Review Mechanism of Medical Devices
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2024, 41(5): 337-345.
|
| [6] |
ZHAO Pin, WANG Xue-mei, LI Yue, WENG Zhi-ying.
The Efficacy and Safety of Neuroaminidase Inhibitors for the Treatment of Influenza: An Overview of Systematic Reviews
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2024, 41(4): 314-320.
|
| [7] |
CHENG Mao-bo, PENG Liang, GUO Xiao-lei, JU Shan, MU Lan-lan, ZHANG Xu.
Regulatory Considerations for Clinical Trial Approval of Medical Devices
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2024, 41(2): 85-87.
|
| [8] |
LV Yun-feng, HE Jing-yun, HAN Zhao-zhao.
Evaluation Requirements and Reform Progress of in Vitro Diagnostic Reagents
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2024, 41(1): 10-13.
|
| [9] |
LING Juan, HAO Jiang-hua, LU Wei, HE Bao-feng, LUO Xu-fei, XIE Zhuo-lin, ZHANG Ding-hua, ZHANG Qing-ye, LUO Xiang-xia.
Overviews of Systematic Reviews of Psoriasis with IL-17 Inhibitors Based on GRADE System
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2023, 40(4): 338-343.
|
| [10] |
GAI Ke-ke, JIA Qiong, WANG Zhen-zhen.
Efficacy And Safety of SGLT-2 Inhibitors and DPP-4 Inhibitors Combined with Metformin with Type 2 Diabetes: A Systematic Review
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2022, 39(3): 261-266.
|
| [11] |
LI Jiang, XIAO Yue, ZHANG Jun-hua, TIAN Jin-hui, .
Introduction to the Writing Method of Living Systematic Review
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2022, 39(1): 11-15.
|
| [12] |
CHENG Lu-ying, ZHENG Qing-yong, XU Jian-guo, QING Jia-xin, LI Jun-fang, XIAO Yue, LI Jiang, TIAN Jin-hui, .
Citation Analysis of Living Systematic Review based on Web of Science
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2022, 39(1): 16-21.
|
| [13] |
ZHAO Min, HUANG Cheng-long, HUANG Zhen-guang, ZHONG Qiu-an.
Literature Review of Acute Pancreatitis Induced by Sodium Cotransporter 2 Inhibitors
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2022, 39(1): 75-78.
|
| [14] |
YANG Qing-cheng, SONG Cang-sang, ZHANG Yang, ZHANG Han-shu.
Influence of Genetic Polymorphism on Anticoagulation Dosage of Warfarin
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2021, 38(6): 531-535.
|
| [15] |
XU Jian-guo, ZHENG Qing-yong, CHENG Lu-ying, QIN Jia-xin, CHEN Tao, XIAO Yue, LI Jiang, TIAN Jin-hui, .
Introduction of the Origin and Development of Living Systematic Review
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2021, 38(6): 465-470.
|